CSIMarket
 
Icagen, Inc.  (ICGND)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Icagen's Suppliers Performance

ICGND's Supply Chain




 
ICGND Costs vs Sales of Suppliers Growth Icagen recorded an increase in cost of sales by 125.71 % year on year, sequentially cost of sales grew by 6.25 % in Q3.

More on ICGND Suppliers



Icagen recorded increase in cost of sales by 125.71 % year on year, sequentially cost of sales grew by 6.25 % in Q3.

More on ICGND Suppliers




Icagen's Comment on Supply Chain









ICGND's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Icagen, Inc. 0.00 14.08 -14.42 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Icagen, Inc.'s official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Icagen, Inc.’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.